Biofermin R


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 38.7%
Adult T-cell Lymphoma/leukaemia 15.3%
Drug Use For Unknown Indication 13.1%
Constipation 5.1%
Nasopharyngitis 2.9%
Antifungal Prophylaxis 2.7%
Diarrhoea 2.2%
Infection 2.2%
Pneumonia 2.2%
Prophylaxis 2.2%
Pyrexia 2.2%
Lung Abscess 1.7%
Bronchitis 1.5%
Diuretic Therapy 1.5%
Hyperlipidaemia 1.2%
Hypertension 1.2%
Proctitis 1.2%
Stomatitis 1.2%
Depression 1.0%
Gastrooesophageal Reflux Disease 1.0%
Drug Reaction With Eosinophilia And Systemic Symptoms 11.4%
Lung Abscess 8.6%
Pneumonia 8.6%
Pyrexia 8.6%
Diverticulum Intestinal Haemorrhagic 5.7%
Drug Rash With Eosinophilia And Systemic Symptoms 5.7%
Lymphocyte Stimulation Test Positive 5.7%
Pseudomembranous Colitis 5.7%
Stevens-johnson Syndrome 5.7%
Urticaria 5.7%
Vomiting 5.7%
Angina Pectoris 2.9%
Enteritis Infectious 2.9%
Respiratory Disorder 2.9%
Respiratory Failure 2.9%
Stomatitis 2.9%
Thrombocytopenia 2.9%
Transaminases Increased 2.9%
Upper Respiratory Tract Inflammation 2.9%
Concomitant
Asthma 23.3%
Bronchitis 9.2%
Pneumonia 9.2%
Otitis Media 8.9%
Upper Respiratory Tract Inflammation 7.5%
Tonsillitis 5.3%
Prophylaxis 3.8%
Conjunctivitis 3.5%
Prophylaxis Against Dehydration 3.5%
Pseudocroup 3.5%
Product Used For Unknown Indication 3.5%
Drug Use For Unknown Indication 2.9%
Diarrhoea 2.7%
Enterocolitis 2.2%
Pyrexia 2.1%
Gastroenteritis 1.8%
Rhinitis 1.8%
Prophylaxis Against Diarrhoea 1.8%
Dehydration 1.8%
Otitis Media Acute 1.8%
Acute Tonsillitis 16.1%
Rhinitis 16.1%
Sinusitis 16.1%
Vomiting 6.4%
White Blood Cell Count Decreased 5.9%
Pneumonia 4.3%
Sepsis 4.3%
Stomatitis 3.8%
Interstitial Lung Disease 3.6%
Pyrexia 3.6%
Platelet Count Decreased 2.6%
Somnolence 2.3%
White Blood Cell Count Increased 2.3%
Liver Disorder 2.0%
C-reactive Protein Increased 1.8%
Hepatic Function Abnormal 1.8%
Histiocytosis Haematophagic 1.8%
Rash 1.8%
Renal Impairment 1.8%
Weight Decreased 1.8%

Drug Data